{"nct_id":"NCT06119581","title":"A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2023-12-21","start_date_type":"ACTUAL","primary_completion_date":"2026-10","primary_completion_date_type":"ESTIMATED","completion_date":"2029-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}